Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 ...
FDA Drug Recall #D-0175-2023 — Class II — January 13, 2023
Recall Summary
| Recall Number | D-0175-2023 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 13, 2023 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Nephron Sc Inc |
| Location | West Columbia, SC |
| Product Type | Drugs |
| Quantity | 387,000 vials |
Product Description
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4
Reason for Recall
Short Fill
Distribution Pattern
Nationwide within the United States including Puerto Rico. Guatamala
Lot / Code Information
Lot #: 126451 Exp. 04/30/2023
Other Recalls from Nephron Sc Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0364-2023 | Class II | Sterile Water for Injection, USP, 30x5 mL Singl... | Feb 23, 2023 |
| D-0176-2023 | Class II | S2 Racepinephrine Inhalation Solution, USP 2.25... | Jan 13, 2023 |
| D-0177-2023 | Class II | 0.9% Sodium Chloride Injection, USP, 100 mL Sin... | Jan 12, 2023 |
| D-0178-2023 | Class II | Sterile Water for Injection, USP, For Drug Dilu... | Jan 12, 2023 |
| D-1354-2022 | Class II | Ketorolac Tromethamine Injection, USP 60 mg/2 m... | Aug 10, 2022 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.